Filter
4530
Filtered Results: 4530
Text search:
drug
policy
Featured
Recommendations
370
New Publications
1260
Language
Document type
No document type
2860
Studies & Reports
663
Guidelines
507
Manuals
175
Strategic & Response Plan
150
Fact sheets
56
Training Material
45
Situation Updates
45
Infographics
11
Resource Platforms
8
Online Courses
5
Brochures
4
App
1
Countries / Regions
India
216
Kenya
155
Global
130
Uganda
115
South Africa
112
Western and Central Europe
108
Ethiopia
105
Nigeria
104
Nepal
92
Liberia
82
Malawi
79
Sierra Leone
78
Zambia
75
Tanzania
74
Myanmar / Burma
72
Ghana
68
Africa
64
Bangladesh
61
Latin America and the Carribbean
61
Eastern Europe
59
Ukraine
54
Rwanda
52
Namibia
48
Zimbabwe
41
Asia
40
Philippines
36
Cambodia
35
Lesotho
35
South–East Asia Region
35
Russia
33
Indonesia
32
Botswana
28
Eswatini/ Swaziland
22
Congo, Democratic Republic of
21
Mozambique
21
Senegal
20
Syria
19
Burkina Faso
18
Brazil
15
East and Southern Africa
15
West and Central Africa
13
Colombia
12
Middle East and North Africa
12
Venezuela
12
Cameroon
11
Haiti
11
Pakistan
11
South Sudan
11
Eastern Europe and Central Asia
11
Guinea
10
Germany
10
Thailand
10
Albania
10
Tajikistan
10
Georgia
10
Sudan
9
USA
7
Afghanistan
7
Moldova
7
Vietnam
7
China
6
Benin
6
North Macedonia
6
Yemen
6
Paraguay
6
Armenia
6
Laos
6
Peru
5
Mexico
5
Sri Lanka
5
Western Pacific Region
5
Somalia
4
Iraq
4
Jordan
4
Central African Republic
4
Argentina
4
El Salvador
4
Libya
4
Bhutan
4
United Kingdom
4
Lebanon
3
Turkey
3
Fiji
3
Palestine
3
Southern Africa
3
Timor Leste/ East Timor
3
Estonia
3
Iran
3
Kyrgyzstan
3
North America
3
Jamaica
3
Mali
2
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Papua New Guinea
2
Serbia
2
Hungary
2
Bolivia
2
Chile
2
Poland
2
Canada
2
Romania
2
Uzbekistan
2
Kazakhstan
2
Gabon
2
Belgium
2
Portugal
2
Belarus
2
Guinea-Bissau
1
Egypt
1
Gambia
1
Ireland
1
Switzerland
1
Greece
1
Angola
1
Madagascar
1
North Korea
1
Italy
1
Mongolia
1
Qatar
1
Bulgaria
1
Lithuania
1
Uruguay
1
Turkmenistan
1
Denmark
1
France
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Spain
1
Authors & Publishers
Publication Years
Category
Countries
1828
Clinical Guidelines
373
Public Health
230
Women & Child Health
170
Key Resources
89
Pharmacy & Technologies
51
Capacity Building
49
Toolboxes
HIV
598
TB
504
Mental Health
413
AMR
246
COVID-19
168
Pharmacy
138
NTDs
92
NCDs
87
Caregiver
79
Planetary Health
67
Rapid Response
60
Ebola
59
Global Health Education
55
Disability
53
Refugee
51
Conflict
46
Health Financing Toolbox
31
Polio
23
Natural Hazards
16
Specific Hazards
13
Cholera
9
Social Ethics
9
Zika
6
Health Financing
1
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
La carga de la diabetes es enorme, posicionándola como uno de los principales desafíos que enfrenta la salud pública en la actualidad. Actualmente, se estima que 62 millones de personas viven con diabetes en la Región de las Américas y las proyecciones muestran que su prevalencia seguirá aumen...
The Commission on Macroeconomics and Health (CMH) was established by World Health Organization Director-General Gro Harlem Brundtland in January 2000 to assess the place of health in global economic development. Although health is widely understood to be both a central goal and an important outcome ...
Financing Global Health 2015 is the seventh edition of IHME’s annual series on global health financing. This report captures trends in development assistance for health (DAH) and government health expenditure as source (GHE-S) in low- and middle-income countries. Annually updated GHE-S and DAH est...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
Access to safe blood and blood products is recognized as one of the key requirements for delivery of modern health care in the journey towards health for all. The foundation of safe and sustainable blood supplies depends on the collection of blood from voluntary non-remunerated and low-risk donors. ...
This report compiles data for the first time on the far-reaching consequences of uncontrolled hypertension, including heart attacks, strokes and premature death, along with substantial economic losses for communities and countries. It also contains information on the global, regional and country-lev...
Building on the 2021 Interim guidance, this second version and update, incorporates the lessons and feedback from the hepatitis pilots that successfully demonstrated the feasibility of measuring hepatitis B and C impact targets to demonstrate elimination, whilst highlighting challenges caused by hig...
In In recent years, China has increased its international engagement in health. Nonetheless, the lack
of data on contributions has limited efforts to examine contributions from China. Existing estimates that track
development assistance for health (DAH) from China have relied primarily on one data...
What countries need: Investments needed for 2010 targets
Prompt, effective antimalarial treatment, and supportive care can substantially reduce the rate of mortality from severe malaria. However, many children in malaria-endemic countries do not have access to health facilities or a qualified health care provider and do not receive the necessary care in a...
This country cooperation strategy (CCS) outlines how the World Health Organization (WHO) will work with the Lao People’s Democratic Republic over the next five years (2024–2028), supporting the implementation of the five-year health sector development plans and the Health Sector Reform Strategy ...
This document lays out economic arguments for investing in the Access to COVID-19 Tools Accelerator (ACT-Accelerator). Framed within an overall context that recognizes the broader human health and societal impacts of the COVID-19 crisis, ACT-Accelerator's Economic Investment Case argues that investm...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to prevent and control CVD, in addition to multisector...
Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and
dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest
in their ND&IS and little is known about current financing alloca...
Hypertension is referred to as a “silent killer”. Most people with hypertension are unaware of their condition as in most cases, they experience no warning signs or symptoms hence they are not identified or treated. Hypertention is associated with a number of conditions, disability, and causes o...
This technical report has been developed within the framework of the WHO Global Initiative for
Childhood Cancer. Its goal is to improve the situation of children and adolescents with cancer worldwide,
giving them the best chances of survival, living a full life and, above all, enjoying quality of ...
The World Heart Federation (WHF) commenced a Roadmap initiative in 2015 to reduce the global burden of cardiovascular disease and resultant burgeoning of healthcare costs. Roadmaps provide a blueprint for implementation of priority solutions for the principal cardiovascular diseases leading to death...
Many low- and middle-income countries (LMICs) are undergoing an epidemiological transition. With an improvement in socioeconomic conditions and an aging population, cardiovascular diseases (CVDs), like cardiac arrhythmias, are expected to increase in these countries. However, there are limited studi...
Vaccines are powerful weapons in the fight against pandemic viruses as shown by responses to both the 2009 H1N1 influenza and the COVID-19 pandemics. However, planning for accessing, allocating and deploying vaccines in a pandemic situation is a complex endeavour, beset with multiple challenges at a...
